|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
61,660,000 |
Market
Cap: |
48.98(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.6394 - $5.82 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile AlloVir is a late clinical-stage cell therapy company developing allogeneic T-cell therapies to treat and prevent devastating viral diseases. Co.'s Pipeline includes: Posoloeucel, which is an allogeneic, off-the-shelf virus-specific T cell (VST) therapy candidate targeting adenovirus, BK virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus 6 and JC virus that can lead to devastating viral disease in the allogeneic hematopoietic cell transplant population; and ALVR106, which is an allogeneic, off-the-shelf VST therapy candidate developed to target devastating diseases caused by human metapneumovirus, influenza, parainfluenza virus and respiratory syncytial virus.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
2,930,870 |
2,930,870 |
Total Buy Value |
$0 |
$0 |
$10,990,763 |
$10,990,763 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
115,969 |
172,535 |
243,925 |
1,567,677 |
Total Sell Value |
$79,638 |
$129,130 |
$336,471 |
$10,296,983 |
Total People Sold |
4 |
4 |
4 |
7 |
Total Sell Transactions |
21 |
34 |
55 |
104 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hagen Brett R |
Chief Accounting Officer |
|
2024-04-22 |
4 |
S |
$0.75 |
$360 |
D/D |
(480) |
77,619 |
|
-4% |
|
Miller Edward |
General Counsel |
|
2024-04-22 |
4 |
S |
$0.75 |
$568 |
D/D |
(757) |
223,227 |
|
-4% |
|
Sinha Vikas |
See Remarks |
|
2024-04-22 |
4 |
S |
$0.75 |
$1,393 |
D/D |
(1,857) |
1,138,096 |
|
-4% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-04-19 |
4 |
S |
$0.75 |
$355 |
D/D |
(473) |
78,099 |
|
-6% |
|
Miller Edward |
General Counsel |
|
2024-04-19 |
4 |
S |
$0.75 |
$470 |
D/D |
(626) |
223,984 |
|
-6% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-04-19 |
4 |
S |
$0.75 |
$7,207 |
D/D |
(9,601) |
802,935 |
|
-6% |
|
Sinha Vikas |
See Remarks |
|
2024-04-19 |
4 |
S |
$0.75 |
$1,142 |
D/D |
(1,521) |
1,139,953 |
|
-6% |
|
Miller Edward |
General Counsel |
|
2024-04-02 |
4 |
S |
$0.77 |
$284 |
D/D |
(368) |
224,610 |
|
-4% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-04-02 |
4 |
S |
$0.77 |
$217 |
D/D |
(281) |
78,572 |
|
-4% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-04-02 |
4 |
S |
$0.77 |
$1,183 |
D/D |
(1,533) |
812,536 |
|
-4% |
|
Sinha Vikas |
See Remarks |
|
2024-04-02 |
4 |
S |
$0.77 |
$683 |
D/D |
(885) |
1,141,474 |
|
-4% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-02-21 |
4 |
S |
$0.71 |
$3,650 |
D/D |
(5,155) |
814,069 |
|
-12% |
|
Sinha Vikas |
See Remarks |
|
2024-02-20 |
4 |
S |
$0.70 |
$2,011 |
D/D |
(2,893) |
1,142,359 |
|
-13% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-02-20 |
4 |
S |
$0.70 |
$343 |
D/D |
(494) |
78,853 |
|
-13% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-02-20 |
4 |
S |
$0.70 |
$2,153 |
D/D |
(3,097) |
819,224 |
|
-13% |
|
Miller Edward |
General Counsel |
|
2024-02-20 |
4 |
S |
$0.70 |
$268 |
D/D |
(385) |
224,978 |
|
-13% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-02-08 |
4 |
S |
$0.67 |
$7,494 |
D/D |
(11,150) |
79,347 |
|
-18% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-02-05 |
4 |
S |
$0.67 |
$27,752 |
D/D |
(41,421) |
822,321 |
|
-19% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-02-05 |
4 |
S |
$0.67 |
$3,881 |
D/D |
(5,792) |
90,497 |
|
-19% |
|
Sinha Vikas |
See Remarks |
|
2024-02-05 |
4 |
S |
$0.67 |
$12,282 |
D/D |
(18,331) |
1,145,252 |
|
-19% |
|
Miller Edward |
General Counsel |
|
2024-02-05 |
4 |
S |
$0.67 |
$5,942 |
D/D |
(8,869) |
225,363 |
|
-19% |
|
Brainard Diana |
Chief Executive Officer |
|
2024-01-23 |
4 |
S |
$0.67 |
$6,369 |
D/D |
(9,500) |
863,742 |
|
-19% |
|
Hagen Brett R |
Chief Accounting Officer |
|
2024-01-23 |
4 |
S |
$0.67 |
$604 |
D/D |
(901) |
96,289 |
|
-19% |
|
Sinha Vikas |
See Remarks |
|
2024-01-23 |
4 |
S |
$0.67 |
$2,150 |
D/D |
(3,205) |
1,163,583 |
|
-19% |
|
Miller Edward |
General Counsel |
|
2024-01-23 |
4 |
S |
$0.67 |
$873 |
D/D |
(1,302) |
234,232 |
|
-19% |
|
288 Records found
|
|
Page 1 of 12 |
|
|